Ho; Mitchell

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ho; Mitchell.The latest application filed is for "high affinity monoclonal antibodies targeting glypican-1 and methods of use".

Company Profile

4.17.20

Ho; Mitchell - Sydney AU
Ho; Mitchell - Urbana MD
Ho; Mitchell - Bethesda MD
Ho; Mitchell - North Potomac MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Detecting community in radio access networks with a plurality of vertices Grant 11,432,166 - Frank , et al. August 30, 2	2022-08-30
Anti-mesothelin polypeptides and proteins Grant 11,390,683 - Pastan , et al. July 19, 2	2022-07-19
High Affinity Monoclonal Antibodies Targeting Glypican-1 And Methods Of Use App 20220098323 - Ho; Mitchell ; et al.	2022-03-31
Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors App 20220064324 - Ho; Mitchell ; et al.	2022-03-03
Chimeric Antigen Receptors Targeting Tumor Antigens App 20210371542 - Ho; Mitchell ; et al.	2021-12-02
High Affinity Monoclonal Antibodies Targeting Glypican-2 And Uses Thereof App 20210292428 - Ho; Mitchell ; et al.	2021-09-23
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof Grant 11,066,479 - Ho , et al. July 20, 2	2021-07-20
Anti-mesothelin Polypeptides And Proteins App 20200247901 - Kind Code	2020-08-06
Immunotoxins With Albumin Binding Domain App 20200223937 - Pastan; Ira H. ; et al.	2020-07-16
Monoclonal Antibodies Targeting Glypican-2 (gpc2) And Use Thereof App 20200216558 - Ho; Mitchell ; et al.	2020-07-09
Community Detection in Radio Access Networks with Constraints App 20200196168 - Frank; Philipp ; et al.	2020-06-18
Human monoclonal antibodies specific for glypican-3 and use thereof Grant 10,640,571 - Ho , et al.	2020-05-05
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof App 20180134800 - Ho; Mitchell ; et al.	2018-05-17
Human monoclonal antibodies specific for glypican-3 and use thereof Grant 9,932,406 - Ho , et al. April 3, 2	2018-04-03
Mesothelin domain-specific monoclonal antibodies and use thereof Grant 9,803,022 - Ho , et al. October 31, 2	2017-10-31
Mesothelin antibodies and methods for eliciting potent antitumor activity Grant 9,416,190 - Ho , et al. August 16, 2	2016-08-16
Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof App 20160229919 - Ho; Mitchell ; et al.	2016-08-11
High-affinity monoclonal antibodies to glypican-3 and use thereof Grant 9,409,994 - Ho , et al. August 9, 2	2016-08-09
Mesothelin domain-specific monoclonal antibodies and use thereof Grant 9,409,992 - Ho , et al. August 9, 2	2016-08-09
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof App 20160208015 - Ho; Mitchell ; et al.	2016-07-21
Human monoclonal antibodies specific for glypican-3 and use thereof Grant 9,394,364 - Ho , et al. July 19, 2	2016-07-19
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof App 20150368340 - Ho; Mitchell ; et al.	2015-12-24
Human monoclonal antibodies specific for glypican-3 and use thereof Grant 9,206,257 - Ho , et al. December 8, 2	2015-12-08
Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity App 20150274836 - Ho; Mitchell ; et al.	2015-10-01
Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof App 20150252118 - Ho; Mitchell ; et al.	2015-09-10
High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof App 20150147330 - Ho; Mitchell ; et al.	2015-05-28
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof App 20140044714 - Ho; Mitchell ; et al.	2014-02-13
Blocking mesothelin peptide fragments Grant 8,623,828 - Ho , et al. January 7, 2	2014-01-07
Anti-mesothelin antibodies Grant 8,460,660 - Ho , et al. June 11, 2	2013-06-11
Anti-mesothelin Antibodies App 20120107933 - Ho; Mitchell ; et al.	2012-05-03
Blocking Mesothelin Peptide Fragments App 20110236385 - Ho; Mitchell ; et al.	2011-09-29
Mutated anti-cd22 antibodies and immunoconjugates Grant 7,982,011 - Pastan , et al. July 19, 2	2011-07-19
Mutated anti-cd22 antibodies and immunoconjugates App 20070189962 - Pastan; Ira H. ; et al.	2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.